Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Date

01

Attendees:

(bolded names indicate attendance)

Stakeholder group

SHIELD organization

Name of SHIELD member

organization designation

Industry Entity

Labgnostic, Inc.

Steve Box

primary

 

Andy Harris

alternate

Epic

Dan Rutz

primary

 

 

alternate

Biomerieux

Xavier Gansel

primary

 

 

alternate

Roche

Nick Decker

primary

Roche

Yue Jin

alternate

Healthcare Provider

Indiana University/Indiana University Health/Association for Molecular Pathology

Mehdi Nassiri, MD

primary

University of Wisconsin-Madison

Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA

primary

UT Southwestern Medical Center

Hung Luu

primary

UNMC

Scott Campbell

primary

Tufts Medical Center

Nanguneri Nirmala

primary

Sonic Healthcare

Eric Crugnale

primary

Former Quest Diagnostics

Collom, Craig D

primary

Patient Advocate

 

Stacy Lange

individual

Standards Organization

SNOMED International

 

James T. Case

primary

Monica Harry

alternate

Regenstrief Institute

 

Marjorie Rallins

primary

Eza Hafeza

alternate

HL7

 

Julia Skapik

primary

 

alternate

Professional Organization

Association of Public Health Laboratories

 

Riki Merrick

primary

Dari Shirazi

alternate

Graphite Health

 

Stan Huff

primary

 

alternate

CAP

 

Raj Dash

primary

 

alternate

AMP

 

Robyn Temple

primary

 

alternate

Governmental - non Voting

CMS

OPEN

primary

 

alternate

ONC

Sara Armson

primary

 

alternate

CDC

Hubert Vesper (/DDNID/NCEH/DLS)

primary

Jasmine Chaitram -

alternate

NLM

 John Snyder

primary

 

alternate

FDA

 Keith

 Keith Campbell

primary

 Victoria Derbyshire

alternate

Agenda and Notes

em

Notes

Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 19 named members, so 2/3 = 12 (excluding chair and government members).

 

Open Meeting

Follow up Items

  • Special Topic calls:

    • Confirmed:

      • LOINC extension in SNOMED CT (Stan and Jim): Dec 12th

      • Synensys Final Report (Alana team) : Jan 9th

      • LOINC Naming Call (Pam): Feb 13th

    • Proposed:

      • State of Interoperability in the UK - March 12th

      • Netherlands perspective

    • Patient Generated Health Data topic -

any update?
    • LOINC Lab meetign is discussing and will bring back to SHIELD, when ready

Presentations etc

  • FDA Collaborative Community is holding a virtual panel “The Power of Data” on Dec 13th 12:30 - 2 PM ET for CDRH staff - Andrea

wil
  • will be representing

  • Children’s Health Laboratory Medicine Conference Feb 16 - Andrea and Riki will present SHIELD overview with the specific viewpoint around impact of SHIELD work on laboratorians

Review Working Groups progress

Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid

2024/25 Conferences we might want to submit abstracts to

Eric and
  • Steve will be attending - need any help?

  • ADLM (submission deadlines for 2024 presentations passed, but consider 2025)

  • API (submission deadlines for 2024 presentations passed, but consider 2025)

Roadmap section updates in response to ONC comments on the SHIELD roadmap

We will talk about approach to updates in general and these specific comments in particular related to the ONC comments - GOAL READY FOR REVIEW by SC for Jan 2, 2024

Next calls

All SHIELD:

Special Topic: December 12, 2023

General Updates: December 19, 2023

SC: January 2, 2023

Announcement

Remember to sign up for HL7 Ballots = closes Dec 21, 2023

ONC Annual Meeting - APHL was asked to speak to Barriers in Lab Interoperability and their involvement in SHIELD (Friday PM session)

Adjourned

...

12:30 PM ET

From Chat:

-no items-

Action items

  •  

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

    Decisions requiring context or tracking

    For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.

    Create from Template
    spaceKeyCLP
    blueprintModuleCompleteKeycom.atlassian.confluence.plugins.confluence-business-blueprints:decisions-blueprint
    contentBlueprintId7df0012f-f16f-4314-9440-69be210d9c3c
    templateName7df0012f-f16f-4314-9440-69be210d9c3c
    buttonLabelCreate decision from decision template